• 中国精品科技期刊
  • 中国高校百佳科技期刊
  • 中国中文核心期刊
  • 中国科学引文数据库核心期刊
Advanced Search
ZHONG Chunmei, MA Yan, WANG Yandong, YANG Wei, HAN Zhong, SUN Jingjing, LIN Baoqin. Effect of Danhong Huayu Koufuye combined with insulin on prevention and progression of early diabetic nephropathy in rats[J]. Journal of China Pharmaceutical University, 2013, 44(6): 568-572. DOI: 10.11665/j.issn.1000-5048.20130616
Citation: ZHONG Chunmei, MA Yan, WANG Yandong, YANG Wei, HAN Zhong, SUN Jingjing, LIN Baoqin. Effect of Danhong Huayu Koufuye combined with insulin on prevention and progression of early diabetic nephropathy in rats[J]. Journal of China Pharmaceutical University, 2013, 44(6): 568-572. DOI: 10.11665/j.issn.1000-5048.20130616
shu

Effect of Danhong Huayu Koufuye combined with insulin on prevention and progression of early diabetic nephropathy in rats

More Information
    Graphical Abstract
    • Abstract
  • Danhong Huayu Koufuye (DHK), a traditional Chinese prescription, has activities of promoting blood circulation to remove blood stasis and promoting qi circulation to remove meridian obstruction. The aim of the study was to investigate effects of DHK, insulin and their combination on diabetic nephropathy(DN)in streptozotocin(STZ, 50 mg/kg, ip)-induced diabetic Sprague-Dawley rats. Rats were divided into five groups: normal control, model control, insulin, DHK, and DHK plus insulin. The animals were treated once daily for 15 weeks starting one week after STZ injection. The combination of DHK with insulin resulted in more significant effects than insulin or DHK alone on decreasing fasting blood glucose, 24 h water intake, diet intake and urine volume, reducing serum urea level and urea-to-Cr ratio, promoting kidney hypertrophy and renal damage, and increasing serum Na+ and Cl- level as well. These results suggest that DHK may be a valuable adjuvant therapy for DN.
    • FullText(HTML)
    • References (14)
  • [1]
    Dalla Vestra M,Saller A,Bortoloso E,et al.Structural involvement in type 1 and type 2 diabetic nephropathy[J].Diabetes Metab,2000, 26(Suppl 4):8-14.
    [2]
    Yokoyama H,Okudaira M,Otani T,et al.Higher incidence of diabetic nephropathy in type 2 than in type 1 diabetes in early-onset diabetes in Japan[J].Kidney Int,2000, 58(1):302-311.
    [3]
    Maric C,Hall JE.Obesity,metabolic syndrome and diabetic nephropathy[J].Contrib Nephrol,2011, 170:28-35.
    [4]
    Tripathi YB,Yadav D.Diabetic nephropathy:causes and managements[J].Recent Pat Endocr Metab Immune Drug Discov,2013, 7(1):57-64.
    [5]
    Chinese Pharmacopoeia Commission.Danhong Huayu Koufuye.Pharmacopoeia of the People′s Republic of China [M].2010, 1(3):613-615.
    [6]
    Lin BQ,Zhou JY,MaY,et al.Preventive effect of Danhong Huayu Koufuye on diabetic retinopathy in rats[J].Int J Ophthalmol,2011, 4(6):599-604.
    [7]
    The Diabetes Control and Complications Trial/Epidemiology diabetes interventions and complications research group.Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy[J].N Engl J Med,2000, 342:381-389.
    [8]
    Fioretto P,Bruseghin M,Berto I,et al.Renal protection in diabetes:role of glycemic control[J].J Am Soc Nephrol,2006, 17(4 Suppl 2):S86-S89.
    [9]
    Liu HY,Cao SY,Hong T,et al.Insulin is a stronger inducer of insulin resistance than hyperglycemia in mice with type 1 diabetes mellitus(T1DM)[J].J Biol Chem,2009, 284(40):27 090-27 100.
    [10]
    Dalla VM,Saller A,Bortoloso E,et al.Structural involvement in type 1 and type 2 diabetic nephropathy[J].Diabetes Metab,2000, 26(Suppl 4):8-14.
    [11]
    Dabla PK.Renal function in diabetic nephropathy[J].World J Diabetes,2010, 1(2):48-56.
    [12]
    Hartner A,Cordasic N,Klanke B,et al.Renal injury in streptozotocin-diabetic Ren2-transgenic rats is mainly dependent on hypertension,not on diabetes[J].Am J Physiol Renal Physiol,2007, 292:F820-F827.
    [13]
    Hannedouche TP,Delgado AG,Gnoinsahe DA,et al.Renal hemodynamics and segmental tubular reabsorption in early type 1 diabetes[J].Kidney Int,1990, 37(4):1 126-1 133.
    [14]
    Salman IM,Ameer OZ,Sattar MA,et al.Characterization of renal hemodynamic and structural alterations in rat models of renal impairment:role of renal sympathoexcitation[J].J Nephrol,2011, 24(1):68-77.
    • Related Articles

  • Related Articles

    [1]YANG Ruocong, DUAN Feipeng, CHAO Jiahong, TIAN Pengpeng, YAN Zhiyong, LI Shaojing. Advances of microRNA activity in innate immunity[J]. Journal of China Pharmaceutical University, 2017, 48(4): 396-406. DOI: 10.11665/j.issn.1000-5048.20170403
    [2]SI Lianghui, MA Hui, ZHOU Jinpei, ZHANG Huibin. Advances in antidiabetic small molecule ABHD6 inhibitors[J]. Journal of China Pharmaceutical University, 2017, 48(2): 125-134. DOI: 10.11665/j.issn.1000-5048.20170201
    [3]WU Shiwei, ZHANG Hui, LI Qianbin, HU Gaoyun. Advances in thioredoxin reductase and its inhibitors[J]. Journal of China Pharmaceutical University, 2016, 47(5): 511-520. DOI: 10.11665/j.issn.1000-5048.20160502
    [4]XIN Minhang, ZHANG Sanqi. Advances in PI3Kδ selective inhibitors[J]. Journal of China Pharmaceutical University, 2016, 47(5): 503-510. DOI: 10.11665/j.issn.1000-5048.20160501
    [5]YAO Guilin, WANG Haiyong, LU Tao. Advances of the uricosuric drugs[J]. Journal of China Pharmaceutical University, 2016, 47(4): 491-496. DOI: 10.11665/j.issn.1000-5048.20160417
    [6]LIU Kejun, ZHANG Zhimin, RAN Ting, CHEN Hongli, LU Tao, CHEN Yadong. Advances in BET bromodomain protein inhibitors[J]. Journal of China Pharmaceutical University, 2015, 46(3): 264-271. DOI: 10.11665/j.issn.1000-5048.20150302
    [7]LI Tonghui, GUO Hao, LU Tao, WANG Yue, LU Shuai, TANG Weifang. Advances in the research of FLT3 inhibitors for acute myeloid leukemia[J]. Journal of China Pharmaceutical University, 2015, 46(2): 153-161. DOI: 10.11665/j.issn.1000-5048.20150203
    [8]LI Chunhong, DU Hongjin, WEN Xiao′an, SUN Hongbin. Advances in inhibitors of MDM2 and MDM4[J]. Journal of China Pharmaceutical University, 2015, 46(1): 1-15. DOI: 10.11665/j.issn.1000-5048.20150101
    [9]Advances in the research of factor Xa inhibitors[J]. Journal of China Pharmaceutical University, 2010, 41(2): 104-111.
    [10]Advances in Selective COX-2 Inhibitors[J]. Journal of China Pharmaceutical University, 2003, (3): 1-6.

Catalog

    Get Citation
    PDF
    XML
    Article views (1216) PDF downloads (2369) Cited by()
    Turn off MathJax
    Article Contents
    Abstract
    References
    Related Articles

    Copyright © Journal of China Pharmaceutical University苏ICP备12050101号-2

    Address：24 Tongjia Lane, Nanjing City, Jiangsu Province （210009）Tel: 025-83271566E-mail: xuebao@cpu.edu.cn

    Supported by: Beijing Renhe Information Technology Co., Ltd.  Baidu Analytics

    Total visits：292742

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return